Fusion Pharmaceuticals Inc 's

• FUSN's Stock Performance relative to its Competitors

Vertex Pharmaceuticals Inc Share Performance -2.44% 30 Days

Vertex Pharmaceuticals Inc Profile Vertex Pharmaceuticals Incs business model centers on the research and development of innovative therapies, primarily targeting cystic fibrosis and other serious diseases. They emphasize collaboration with organizations, strategic partnerships, and robust investment in R&D to deliver transformative treatments to patients and enhance their quality of life. More about Vertex Pharmaceuticals Inc's Market Share

Gilead Sciences Inc Share Performance -4.38% Over The Past 5 Days

Gilead Sciences Inc Profile Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally. More about Gilead Sciences Inc 's Market Share

Exelixis Inc Share Performance -4.87% Over The Past 5 Days

Exelixis Inc Profile Exelixis Inc's business model is focused on the discovery, development, and commercialization of innovative therapies for the treatment of cancer. More about Exelixis Inc 's Market Share

Cardiol Therapeutics inc Share Performance -6.94% Over The Past 5 Days

Cardiol Therapeutics inc Profile Cardiol Therapeutics Inc. operates on a business model focused on the research and development of pharmaceutical-grade cannabidiol (CBD) and targeted therapies for cardiovascular diseases. The company aims to leverage its expertise to develop innovative and effective treatments to address unmet medical needs in the field of heart-related conditions. More about Cardiol Therapeutics inc 's Market Share

Cullinan Therapeutics Inc Share Performance +212.86% One Year

Cullinan Therapeutics Inc Profile Cullinan Oncology Inc's business model focuses on developing innovative cancer treatments by identifying and acquiring promising drug candidates through collaborations and partnerships with academic institutions and biotechnology companies. They prioritize the advancement of these therapies towards clinical trials and commercialization, aiming to address unmet medical needs in the field of oncology. More about Cullinan Therapeutics Inc 's Market Share

Sources: Fusion Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:39 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Fusion Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.